IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain

  • Post author:
  • Post category:BioPharma

  Life Sciences Jobs   ... Source: BioSpace

Continue ReadingIntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain

31-Year-Old Biotech Guru Brings in Another $55 Million for Axovant

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-axovant-sciences-vivek-ramaswamy.jpg" NAME"31-Year-Old Biotech Guru Brings in Another $55 Million for Axovant" ALT"31-Year-Old Biotech Guru Brings in Another $55 Million for Axovant"February 3, 2017By Alex Keown, BioSpace... Source: BioSpace

Continue Reading31-Year-Old Biotech Guru Brings in Another $55 Million for Axovant